Steven E. Finkelstein
- Immunology top 0.5%
- Oncology top 0.5%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Genetics top 2%
- Co-authors
- Nicholas P. RestifoSteven A. RosenbergChristopher A. KlebanoffDouglas C. PalmerPaul A. AntonyLuca GattinoniPaul J. SpiessDeborah R. Surman
- Topics
- Immunotherapy and Immune Responses (26 papers)Cancer Immunotherapy and Biomarkers (13 papers)CAR-T cell therapy research (12 papers)
- Journals
- Proceedings of the National Academy of SciencesThe Journal of Experimental MedicineJournal of Clinical Oncology
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Steven E. Finkelstein
70 papers receiving 6.5k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Immunology 4.1k
- Oncology 4.0k
- Pulmonary and Respiratory Medicine 998
- Molecular Biology 982
- Genetics 772
Countries citing papers authored by Steven E. Finkelstein
This map shows the geographic impact of Steven E. Finkelstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven E. Finkelstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven E. Finkelstein more than expected).
Fields of papers citing papers by Steven E. Finkelstein
This network shows the impact of papers produced by Steven E. Finkelstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven E. Finkelstein. The network helps show where Steven E. Finkelstein may publish in the future.
Co-authorship network of co-authors of Steven E. Finkelstein
This figure shows the co-authorship network connecting the top 25 collaborators of Steven E. Finkelstein. A scholar is included among the top collaborators of Steven E. Finkelstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven E. Finkelstein. Steven E. Finkelstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Alleviation of Cancer Therapy-Induced Gastrointestinal Toxicity using an Amino Acid Medical Food | 3 |
| 3 | 92 | |
| 4 | 21 | |
| 5 | 51 | |
| 6 | 167 | |
| 7 | 9 | |
| 8 | 9 | |
| 9 | 94 | |
| 10 | 33 | |
| 11 | 225 | |
| 12 | 101 | |
| 13 | 4 | |
| 14 | 12 | |
| 15 | Synergy of IL-21 and IL-15 in regulating CD8+ T cell expansion and functionbreakdown → | 592 |
| 16 | Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8 + T cellsbreakdown → | 812 |
| 17 | CD8+ T Cell Immunity Against a Tumor/Self-Antigen Is Augmented by CD4+ T Helper Cells and Hindered by Naturally Occurring T Regulatory Cellsbreakdown → | 585 |
| 18 | 481 | |
| 19 | 21 | |
| 20 | 1 |
About Steven E. Finkelstein
Steven E. Finkelstein is a scholar working on Immunology, Oncology and Pulmonary and Respiratory Medicine, having authored 71 papers that have together received 6.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (26 papers), Cancer Immunotherapy and Biomarkers (13 papers) and CAR-T cell therapy research (12 papers). The work is most often cited by research in Immunology (4.1k citations), Oncology (4.0k citations) and Pulmonary and Respiratory Medicine (998 citations). Steven E. Finkelstein has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Nicholas P. Restifo, Steven A. Rosenberg, Christopher A. Klebanoff, Douglas C. Palmer, Paul A. Antony, Luca Gattinoni, Paul J. Spiess, Deborah R. Surman, Leroy N. Hwang and Zhiya Yu. Their work appears in journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.